Local News

FDA Approves GSK Asthma Drug for Younger Children

Posted March 23, 2006

— The U.S. Food and Drug Administration has granted its approval for the winder use of the

GlaxoSmithKline

asthma drug known as Flovent HFA.

Flovent can now be prescribed for children ages 4 to 11, GSK said Thursday.

Some 3.6 million children ages 5-11 have asthma, according to federal health statistics cited by GSK.

Flovent was approved for use for patients ages 12 and older in 2004.

Comments

Please with your WRAL.com account to comment on this story. You also will need a Facebook account to comment.

Oldest First
View all